Webinar - Accelerating First-In-Class and Best-In-Class Programs Using a Large-Scale Digital Chemistry Strategy

May 24, 2022

Time: 11:00 AM ET 
Aleksey Gerasyuto, Vice President, Drug Discovery, Schrödinger
Matthew Bursavich, Vice President, Head of Chemistry, Morphic Therapeutic

Drug discovery organizations across the globe are seeking to accelerate the rate at which they bring safe, effective therapeutics to patients. Yet the bar for clinical compounds remains high as competitive landscapes become crowded and easily druggable targets have been targeted. The most innovative companies are modernizing their R&D organizations with digital solutions that leverage the combined power of large-scale computational workflows and their own team’s scientific expertise to identify higher-quality molecules more rapidly. In this webinar, you’ll learn how a large-scale collaborative digital chemistry strategy is accelerating first-in-class and best-in-class programs across a range of target classes.


  • How the foundational elements of a digital chemistry strategy for molecular design, discovery, and collaboration lead to more efficient design-make-test cycles
  • Strategies for approaching first-in-class and best-in-class programs using structurally enabled computationally-powered workflows
  • Case studies from Schrödinger and Morphic Therapeutic demonstrating the impact on programs from hit identification through lead optimization



Back To Top